Device Trial Radar · NCT05229445
A Continuous Glucose Monitor Based Insulin Bolus Calculator
Last checked: Nov 20, 2026Latest source record: Oct 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
27
Actual
Start
Jul 5, 2022
Primary completion
Sep 28, 2022
Study completion Sep 28, 2022
Sponsor
- Lead sponsor
- WelldocNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 8, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor
Conditions
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
Interventions
continuous glucose monitor based insulin bolus calculatorDevice
Participants will use the bolus calculator with meals to calculate their insulin bolus doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- time in rangeTime frame: 30 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Northwestern University
Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.